Cidara Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CDTX and other ETFs, options, and stocks.

About CDTX

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.

CEO

Jeffrey L. Stein

CEOJeffrey L. Stein

Employees

Employees38

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees38

CDTX Key Statistics

Market cap

235.50M

Market cap235.50M

Price-Earnings ratio

-0.73

Price-Earnings ratio-0.73

Dividend yield

—

Dividend yield—

Average volume

107.63K

Average volume107.63K

High today

$21.93

High today$21.93

Low today

$20.95

Low today$20.95

Open price

$21.37

Open price$21.37

Volume

50.81K

Volume50.81K

52 Week high

$28.42

52 Week high$28.42

52 Week low

$10.14

52 Week low$10.14

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Cidara Therapeutics

Why Robinhood?

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. Show more

CDTX Key Statistics

Analyst ratings

100%

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.